Search filters

List of works by Daniela E. Matei

A Novel ALDH1A1 Inhibitor Targets Cells with Stem Cell Characteristics in Ovarian Cancer.

scientific article

A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic Analyses.

scientific article published on 2 March 2018

A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer

scientific article published on 12 December 2019

A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer

scientific article

A phase I study of lapatinib in combination with carboplatin in women with platinum sensitive recurrent ovarian carcinoma.

scientific article

Activity of 2 methoxyestradiol (Panzem NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: a Hoosier Oncology Group trial.

scientific article

Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: a gynecologic oncology group trial

scientific article

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer

scientific article published on 01 June 2019

Adjuvant therapy for endometrial cancer

scientific article published on 09 April 2014

An Effective Epigenetic-PARP inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA-mutations.

scientific article published on 3 April 2018

An open-label phase Ib dose-escalation study of TRC105 (anti-endoglin antibody) with bevacizumab in patients with advanced cancer

scientific article

Association of chemotherapy and radiotherapy sequence with overall survival in locoregionally advanced endometrial cancer

scientific article published on 16 January 2019

Autocrine activation of PDGFRalpha promotes the progression of ovarian cancer.

scientific article published on March 2006

Biodynamic imaging for phenotypic profiling of three-dimensional tissue culture.

scientific article published on January 2017

Blockade of FGF signaling: therapeutic promise for ovarian cancer

scientific article published on 15 September 2010

CD73: an emerging checkpoint for cancer immunotherapy

scientific article published on 21 June 2019

Carboplatin with Decitabine Therapy, in Recurrent Platinum Resistant Ovarian Cancer, Alters Circulating miRNAs Concentrations: A Pilot Study

scientific article

Chronic physical effects and health care utilization in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group study.

scientific article published on 27 July 2009

Circulating tumor cell detection using a parallel flow micro-aperture chip system

scientific article

Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: potential predictive relationship with tumor HER2 activation status

article

Complete Transcriptome RNA-Seq

scientific article

Concurrent Detection of Cellular and Molecular Cancer Markers Using an Immunomagnetic Flow System

scientific article published on 12 July 2015

Continued chemotherapy after complete response to primary therapy among women with advanced ovarian cancer: a meta-analysis

scientific article

Decitabine reactivated pathways in platinum resistant ovarian cancer.

scientific article

ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer

scientific article published on 21 August 2012

EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells.

scientific article published on 22 August 2016

Endoglin for targeted cancer treatment

scientific article published on February 2014

Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase

scientific article published on August 2007

Epigenetic Attire in Ovarian Cancer: The Emperor's New Clothes

scientific article published on 07 May 2020

Epigenetic resensitization to platinum in ovarian cancer

scientific article published on May 2012

Epigenetic targeting of ovarian cancer stem cells

scientific article

Epigenetic therapies for chemoresensitization of epithelial ovarian cancer.

scientific article

Epithelial Mutations in Endometriosis: Link to Ovarian Cancer

scientific article published on 01 March 2019

Epithelial ovarian cancer experimental models.

scientific article published on 12 August 2013

Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase

scientific article

Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancer

scientific article published on June 2013

Frizzled-7 Identifies Platinum Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis

scientific article published on 10 November 2020

Gene expression in epithelial ovarian carcinoma

scientific article published in September 2002

Genomic and Epigenomic Signatures in Ovarian Cancer Associated with Resensitization to Platinum Drugs.

scientific article published on 11 December 2017

Global DNA methylation profiling technologies and the ovarian cancer methylome

scientific article

High-dose chemotherapy for recurrent ovarian germ cell tumors

scientific article published on 01 December 2014

Hormonal strategies in gynecologic cancer: Bridging biology and therapy

scientific article published on 20 June 2018

Hypermethylation of 18S and 28S ribosomal DNAs predicts progression-free survival in patients with ovarian cancer.

scientific article published on October 2005

IL-6 mediates platinum-induced enrichment of ovarian cancer stem cells

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

scientific article

Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis : a Hoosier Oncology Group trial.

scientific article published in August 2008

In vivo tumor growth of high-grade serous ovarian cancer cell lines

scientific article published on 5 June 2015

Interferon-γ signaling is associated with BRCA1 loss-of-function mutations in high grade serous ovarian cancer

scientific article published on 06 December 2019

Intracellular Doppler Signatures of Platinum Sensitivity Captured by Biodynamic Profiling in Ovarian Xenografts.

scientific article

Intravenous aflibercept in patients with platinum-resistant, advanced ovarian cancer: results of a randomized, double-blind, phase 2, parallel-arm study.

scientific article published on 11 October 2013

Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells.

scientific article

Live tissue viability and chemosensitivity assays using digital holographic motility contrast imaging.

scientific article

Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy

scientific article published on 24 October 2018

Methylomic Signatures of High Grade Serous Ovarian Cancer

scientific article published on 08 December 2020

MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer.

scientific article published on 25 March 2014

Minireview: epigenetic changes in ovarian cancer.

scientific article published on 02 July 2009

N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.

scientific article published on 7 March 2012

NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019

scientific article published on 01 August 2019

NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer.

scientific article published on 04 April 2016

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

scientific article published on 01 April 2019

Novel agents in ovarian cancer.

scientific article published on August 2007

Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer

scientific article published on 27 March 2012

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.

scientific article

Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy.

scientific article published on 08 April 2016

Ovarian Cancer-Why Lipids Matter

scientific article published on 26 November 2019

Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial.

scientific article published on 08 September 2016

PDGF BB induces VEGF secretion in ovarian cancer.

scientific article published on September 2007

PDGF induced microRNA alterations in cancer cells

scientific article

Pembrolizumab in patients with programmed death ligand 1-positive advanced ovarian cancer: Analysis of KEYNOTE-028

scientific article published on 03 December 2018

Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility

scientific article

Phase I, pharmacogenomic, drug-interaction study of sorafenib and bevacizumab in combination with paclitaxel in patients with advanced refractory solid tumors

scientific article published on 26 August 2020

Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago and California Consortia (NCI9322/PHL86)

scientific article published on 28 January 2020

Phase II clinical trial of ixabepilone in patients with recurrent or persistent platinum- and taxane-resistant ovarian or primary peritoneal cancer: a gynecologic oncology group study

scientific article

Postoperative Radiation Therapy for Endometrial Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline.

scientific article published on 6 July 2015

Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity.

scientific article published on 26 March 2018

Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer.

scientific article published on 8 November 2016

Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial.

scientific article published on 12 February 2013

Role of epigenomics in ovarian and endometrial cancers

scientific article published on June 2010

Small Molecules Target the Interaction between Tissue Transglutaminase and Fibronectin

scientific article published on 23 April 2019

Small molecule inhibitors target the tissue transglutaminase and fibronectin interaction

scientific article (publication date: 2014)

Sorafenib in combination with weekly topotecan in recurrent ovarian cancer, a phase I/II study of the Hoosier Oncology Group.

scientific article

TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells

scientific article

Targeting Cancer Stemness in the Clinic: From Hype to Hope

scientific article published on 27 December 2018

Targeting angiogenesis in ovarian cancer.

scientific article published on 18 July 2011

Targeting ovarian tumor cell adhesion mediated by tissue transglutaminase

scientific article published on 17 February 2011

Targeting the Microenvironment in High Grade Serous Ovarian Cancer

scientific article published on 10 August 2018

Targeting the insulin growth factor and the vascular endothelial growth factor pathways in ovarian cancer

scientific article published on 13 June 2012

The Clinical Impact of Cancer Stem Cells

scientific article published on 17 December 2019

The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer

scientific article published on 15 June 2021

The hunt for elusive cancer stem cells.

scientific article published on 26 April 2017

The novel, small-molecule DNA methylation inhibitor SGI-110 as an ovarian cancer chemosensitizer.

scientific article

The platelet-derived growth factor receptor alpha is destabilized by geldanamycins in cancer cells.

scientific article published on November 2006

Tissue Transglutaminase Activates Cancer-Associated Fibroblasts and Contributes to Gemcitabine Resistance in Pancreatic Cancer

scientific article

Tissue Transglutaminase Mediated Tumor-Stroma Interaction Promotes Pancreatic Cancer Progression

scientific article

Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling

scientific article published on 29 July 2008

Tissue transglutaminase regulates interactions between ovarian cancer stem cells and the tumor niche

scientific article published on 6 March 2018

Tissue transglutaminase regulates matrix metalloproteinase-2 in ovarian cancer by modulating cAMP-response element-binding protein activity

scientific article published on 26 March 2009

Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism.

scientific article

Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancer

scientific article

Updates in the Management of Ovarian Germ Cell Tumors

scientific article published on January 1, 2013

Updates on adjuvant chemotherapy and radiation therapy for endometrial cancer

scientific article published on 01 February 2019

siRNA Delivery Using Dithiocarbamate-Anchored Oligonucleotides on Gold Nanorods

scientific article published on 15 November 2018

β-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids

scientific article